Cita APA

Transition at Teva - Blockbuster Drug Copaxone to Lose Patent Protection in 2014. MarketLine, a Progressive Digital Media business.

Citación estilo Chicago

Transition at Teva - Blockbuster Drug Copaxone to Lose Patent Protection in 2014. MarketLine, a Progressive Digital Media business.

Cita MLA

Transition at Teva - Blockbuster Drug Copaxone to Lose Patent Protection in 2014. MarketLine, a Progressive Digital Media business.

Warning: These citations may not always be 100% accurate.